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HIV Tat protein activates plasma kallikrein-kinin system 
in the doxycycline-inducible astrocyte specific HIV-1 Tat 
transgenic mice
Logan Sneed, Fakhri Mahdi, Salahoddin Mohamed, Jason Paris, and Zia Shariat-Madar
Background
• The neurovascular unit (NVU) of the blood-brain barrier (BBB) consists of astrocytes, pericytes, 
neurons and endothelial cells. 
• Cerebral microvessel, as a necessary component of this unit, are responsible for the selectively of 
the passage of molecules from capillaries into the brain parenchyma and vice versa. 
• The NVU as a selective barrier selectivity is compromised when endothelial cells are infected by 
viruses, including HIV, rabies virus, herpes simplex virus, and West Nile Virus (WNV). 
• Infection activates endothelial leading to loss of its integrity such as its anti-inflammatory and anti-
thrombotic properties
• Upon activation, endothelial barrier functions mainly its permeability and selectivity are altered. 
• These changes facilitate plasma leakage and the entry of HIV or HIV particles into the brain 
parenchyma, allowing HIV to spread in the brain.
Project Overview
• We propose that the HIV trans-activator of transcription (Tat) protein 
alters the structure and function of the endothelium, becoming 
prothrombotic and proinflammatory state contributing to the activation 
of the plasma kallikrein kinin system (KKS) and favoring the passage 
of HIV.
Kallikrein Kinin System
Components of Plasma KKS
• High Molecular Weight Kininogen (HK)
• Prekallikrein (PK)
• Factor XII
High Molecular Weight Kininogen
1. IM Sainz. et al, Thromb Haemost, 2007.
1. IM Sainz. et al, Thromb Haemost, 2007.
The contact and intrinsic pathways make up the 
main amplification loops in the coagulation cascade
hShariat-Madar, et al ttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905712/
Research
• We take advantage of the doxycycline (Dox)-inducible brain-specific HIV-1 
Tat (Tat+) transgenic mice to show that an acute very low-level expression of 















• Measuring FXII 
activity
• Measuring FXI 
activity
Standardizing two in 
vitro models









To explore whether HIV 
Tat protein induces 
changes in the structure 
or function of the 
endothelial barrier
• Measuring PK activation on 
HIVTat protein treated 
endothelial cells
• The endothelial membrane
permeability is quantified in 
the presence or absence of 
kallikrein inhibitor 
Data/Observations
HIV Tat protein enhances 
prekallikrein actiovation
• Increased Plasma Kallikrein Levels Is Associated 
With Tat+ Expression in the Doxycycline-Inducible 
Astrocyte Specific HIV-1 Tat transgenic mice
HIV Tat protein enhances plasma 
kallikrein levels
Plasma Kallikrein Levels are  Elevated in the 
Doxycycline-Inducible Astrocyte Specific HIV-1 Tat 
transgenic mice
HIV Tat protein enhances plasma 
kallikrein levels
Plasma Kallikrein activity is inhibited by Kallistop and Soy 
been Trypsin Inhibitor (SBTI)
Conclusion
• Plasma kallikrein activity was associated with HIV Tat expression 
(p < 0.05).
• Kallikrein was generated in a dose- and incubation time-dependent 
manner.
• Plasma kallikrein activity was reduced by kallistop and SBTI with 
IC50 =1.1 M and 1.3 M.
• Plasma kallikrein activity known to increase the plasma kallikrein 
level are associated with HIV Tat protein levels in the doxycycline-
inducible astrocyte specific HIV-1 Tat transgenic mice, suggesting 
that plasma kallikrein-dependent signaling might alter the structure 
and function of the endothelium.
